New Insights into Warm Autoimmune Hemolytic Anemia from Johnson & Johnson's ASH 2024 Presentation Johnson & Johnson has provided critical insights into the severe impact of warm autoimmune hemolytic anemia, highlighting the urgent need for targeted treatments.

New Insights into Warm Autoimmune Hemolytic Anemia from Johnson & Johnson's ASH 2024 Presentation #United_States #San_Diego #Johnson_&_Johnson #Autoimmune_Anemia #nipocalimab